A study with a selective intestinal FXR inhibitor, Gly-MCA, demonstrated a reduction of triglyceride accumulation in the liver, decreased blood glucose levels and increased insulin sensitivity in the murine model of obesity (Gonzalez et al., 2016). Here, INS is linked to obesity due to melanocortin 4 receptor deficiency.